Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment [Phase 2]
A Phase 2 trial evaluates whether a laboratory test can predict which patients with relapsed, metastatic or unresectable non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial evaluating gemcitabine and carboplatin followed by paclitaxel in patients with stage III or stage IV non-small c…
-
CLINICAL_TRIALS research · 2010-07-29Clinical Trial Update: Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer
Clinical trial update focused on tyrosine kinase inhibitors for metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-07-29Clinical Trial Update: Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer [Phase 2]
A Phase II clinical trial evaluating Lucanix in patients with stages II-IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 study comparing paclitaxel/carboplatin/gemcitabine versus gemcitabine/vinorelbine in non-small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer [Phase 2]
A phase 2 clinical trial update describing a PET-guided chemotherapy strategy for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax [Phase 2]
Phase 2 study evaluating weekly docetaxel with four-weekly carboplatin (Carbo-Tax) in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-07-21Clinical Trial Update: Concurrent Chemo-radiation Form NSCLC to a Individualized MLD
A completed clinical trial update on concurrent chemotherapy and radiotherapy for non-small cell lung cancer, focusing on an individualized …
-
CLINICAL_TRIALS trial_result · 2010-07-21Clinical Trial Update: Radiotherapy for NSCLC to a Individualized MLD
A clinical trial update reports on radiotherapy for non-small cell lung cancer using individualized mean lung dose planning. The study statu…
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports a completed Phase I/II study evaluating the combination of bexarotene and gefitinib (Iressa) for non-smal…
-
CLINICAL_TRIALS research · 2010-07-15Clinical Trial Update: DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
A clinical trial update examining how DNA repair gene status relates to outcomes in patients with stage III non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2010-07-12Clinical Trial Update: Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial comparing pre-operative chemotherapy to concurrent chemoradiotherapy in N2-positive IIIA non-small cell lung cancer. The docum…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen [Phase 2]
Phase 2 study of pemetrexed in non-small cell lung cancer and mesothelioma, including patients with pleural effusion or ascites, with result…
-
CLINICAL_TRIALS research · 2010-07-08Clinical Trial Update: Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) [Phase 3]
This update documents a Phase 3 trial (RT1001) evaluating prophylactic cranial irradiation in NSCLC patients who respond to EGFR inhibitors …
-
CLINICAL_TRIALS research · 2010-07-08Clinical Trial Update: Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) [Phase 2]
Phase 2 clinical trial evaluating concurrent Endostar with paclitaxel/carboplatin and radiotherapy for locally advanced non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating the safety and feasibility of combining gene therapy with radiation therapy in patients with non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery [Phase 2]
Phase 2 study evaluating induction chemotherapy with gemcitabine and carboplatin for operable non-small-cell lung cancer prior to surgery.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) [Phase 2]
A Phase 2 trial of temozolomide in pre-selected advanced aerodigestive tract cancers was terminated; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients [Phase 2]
Phase 2 trial in elderly patients with non-small cell lung cancer compares weekly docetaxel alone to weekly docetaxel with gemcitabine. The …
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 randomized trial comparing oral topotecan to docetaxel for second-line non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-16Clinical Trial Update: Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating intermittent docetaxel in combination with erlotinib (Tarceva) for metastatic non-small cell lung cancer has been…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating two regimens of a rebeccamycin analogue in patients with advanced or recurrent non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update on chemotherapy for patients with advanced non-small cell lung cancer. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
This is a completed clinical trial evaluating non-small cell lung cancer using predefined drug-targeting tumor markers.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 2]
A Phase 2 trial evaluated gefitinib as first-line therapy for patients with EGFR-mutant non-small cell lung cancer (adenocarcinoma); the stu…